These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16382295)

  • 1. Chronic erythropoietin treatment limits infarct-size in the myocardium in vitro.
    Bullard AJ; Yellon DM
    Cardiovasc Drugs Ther; 2005 Oct; 19(5):333-6. PubMed ID: 16382295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preconditioning with acute and chronic lithium administration reduces ischemia/reperfusion injury mediated by cyclooxygenase not nitric oxide synthase pathway in isolated rat heart.
    Faghihi M; Mirershadi F; Dehpour AR; Bazargan M
    Eur J Pharmacol; 2008 Nov; 597(1-3):57-63. PubMed ID: 18789320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin (EPO) affords more potent cardioprotection by activation of distinct signaling to mitochondrial kinases compared with carbamylated EPO.
    Sato T; Tanno M; Miki T; Yano T; Sato T; Shimamoto K; Miura T
    Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):401-8. PubMed ID: 20953685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo.
    Bullard AJ; Govewalla P; Yellon DM
    Basic Res Cardiol; 2005 Sep; 100(5):397-403. PubMed ID: 15944807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardioprotective effects of sodium ferulate mediated by nitric oxide on ischemia-reperfusion injured myocardium: experiment with isolated rat hearts].
    Liu JC; Kang J; Shao LJ; He M
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):987-91. PubMed ID: 16759542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sevoflurane post-conditioning reduces rat myocardial ischemia reperfusion injury through an increase in NOS and a decrease in phopshorylated NHE1 levels.
    Cao J; Xie H; Sun Y; Zhu J; Ying M; Qiao S; Shao Q; Wu H; Wang C
    Int J Mol Med; 2015 Dec; 36(6):1529-37. PubMed ID: 26459736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial protection evoked by hyperoxic exposure involves signaling through nitric oxide and mitogen activated protein kinases.
    Ruusalepp A; Czibik G; Flatebø T; Vaage J; Valen G
    Basic Res Cardiol; 2007 Jul; 102(4):318-26. PubMed ID: 17268885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of desflurane-induced preconditioning following ischemia-reperfusion on nitric oxide release in rabbits.
    Tsai SK; Lin SM; Huang CH; Hung WC; Chih CL; Huang SS
    Life Sci; 2004 Dec; 76(6):651-60. PubMed ID: 15567190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart.
    Burley DS; Baxter GF
    Basic Res Cardiol; 2007 Nov; 102(6):529-41. PubMed ID: 17896117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts.
    Hirata A; Minamino T; Asanuma H; Sanada S; Fujita M; Tsukamoto O; Wakeno M; Myoishi M; Okada K; Koyama H; Komamura K; Takashima S; Shinozaki Y; Mori H; Tomoike H; Hori M; Kitakaze M
    Cardiovasc Drugs Ther; 2005 Jan; 19(1):33-40. PubMed ID: 15883754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
    Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
    Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin.
    Rosanio S; Ye Y; Atar S; Rahman AM; Freeberg SY; Huang MH; Uretsky BF; Birnbaum Y
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):27-36. PubMed ID: 16435070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult.
    Huang C; Cui Y; Ji L; Zhang W; Li R; Ma L; Xing W; Zhou H; Chen B; Yu J; Zhang H
    Pharm Biol; 2013 Apr; 51(4):463-73. PubMed ID: 23336403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial role of nitric oxide in infarct size limiting effect of quercetin and rutin against ischemia-reperfusion injury in normal and diabetic rats.
    Challa SR; Akula A; Metla S; Gopal PN
    Indian J Exp Biol; 2011 Mar; 49(3):207-10. PubMed ID: 21452600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of erythropoietin to render jeopardized ischemic myocardium amenable to incremental salvage by early reperfusion.
    French CJ; Zaman AK; Sobel BE
    Coron Artery Dis; 2009 Jun; 20(4):295-9. PubMed ID: 19440068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Darbepoetin alfa protects the rat heart against infarction: dose-response, phase of action, and mechanisms.
    Baker JE; Kozik D; Hsu AK; Fu X; Tweddell JS; Gross GJ
    J Cardiovasc Pharmacol; 2007 Jun; 49(6):337-45. PubMed ID: 17577097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel, selective EPO receptor ligands lacking erythropoietic activity reduce infarct size in acute myocardial infarction in rats.
    Kiss K; Csonka C; Pálóczi J; Pipis J; Görbe A; Kocsis GF; Murlasits Z; Sárközy M; Szűcs G; Holmes CP; Pan Y; Bhandari A; Csont T; Shamloo M; Woodburn KW; Ferdinandy P; Bencsik P
    Pharmacol Res; 2016 Nov; 113(Pt A):62-70. PubMed ID: 27521836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Rho kinase protects from ischaemia-reperfusion injury via regulation of arginase activity and nitric oxide synthase in type 1 diabetes.
    Tratsiakovich Y; Kiss A; Gonon AT; Yang J; Sjöquist PO; Pernow J
    Diab Vasc Dis Res; 2017 May; 14(3):236-245. PubMed ID: 28183205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effects of erythropoietin in rats subjected to ischemia-reperfusion injury: assessment of infarct size with 99mTc-annexin V.
    Doue T; Ohtsuki K; Ogawa K; Ueda M; Azuma A; Saji H; Strauss HW; Matsubara H
    J Nucl Med; 2008 Oct; 49(10):1694-700. PubMed ID: 18794258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardioprotection and mechanisms of exogenous carbon monoxide releaser CORM-2 against ischemia/reperfusion injury in isolated rat hearts].
    Mei DS; Du YA; Wang Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 May; 36(3):291-7. PubMed ID: 17571314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.